Drugs / Opalustre
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT06949878 | May 2025 → Jun 2026 overdue | dental fluorosis | Cairo University | Not yet recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07709286 Comparator | Jan → Jul 2026 overdue | — | Misr University for Science and Technology | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | opalustre | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06949878 ↗ |
| Route | Topical | “Microabrasion will be conducted using Opalustre (Ultradent Products Inc, South Jordan, UT, USA) will be applied onto the stained areas of the teeth.” NCT07709286 ↗ |